Biovail Corp (USA) (NYSE:BVF.DL)

CAPS Rating: No stars

A specialty pharmaceutical company that applies advanced drug-delivery technologies to improve the clinical effectiveness of medicines. Its main therapeutic areas are central nervous system disorders, pain management and cardiovascular disease.

BVF.DL News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top BVF.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Grinnell4Eva (83.52)
Submitted May 30, 2008

Wellbutrin generics should continue to come under pressure from their poor efficacy vis-a-vis the brand name product. Huge buybacks on the horizon. Refocused management has put past scandals behind them and looks to pour cash into R & D pipeline… More

Civildriver (< 20)
Submitted January 03, 2008

BVF stock is a big money losser.

BVF.DL VS S&P 500 (SPY)

BVF.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about BVF.DL.

No one has written a Pitch for BVF.DL stock yet. Tell us why you think BVF.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in BVF.DL.

No players have picked BVF.DL yet. Tell us why you think BVF.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackUBS 93.23 3/25/2010 Outperform NS $16.32 +61.46% -2.86% +64.31 9/28/2010 @ $26.35 0 Comment
TrackPiperJaff 86.65 3/4/2010 Outperform NS $15.30 +72.21% +1.62% +70.59 9/28/2010 @ $26.35 0 Comment
TrackTWeisel 89.23 12/17/2009 Outperform NS $13.52 +94.87% +3.21% +91.67 9/28/2010 @ $26.35 0 Comment
TrackJPMorgan 88.99 9/26/2009 Outperform NS $13.66 +24.44% +13.39% +11.05 4/30/2010 @ $17.00 0 Comment
TrackCreditSuiss 91.35 9/15/2009 Outperform NS $12.87 +104.75% +10.00% +94.75 9/28/2010 @ $26.35 0 Comment
TrackDeutscheSec 87.93 5/8/2009 Outperform NS $10.08 +161.46% +24.17% +137.29 9/28/2010 @ $26.35 0 Comment
TrackCanaccord 67.99 9/17/2008 Outperform NS $8.65 +204.69% -3.49% +208.18 9/28/2010 @ $26.35 0 Comment
TrackBMOCapital < 20 11/20/2007 Underperform NS $14.63 +5.60% +3.05% -2.55 12/5/2007 @ $15.45 0 Comment
TrackDreman 79.37 9/30/2007 Outperform NS $13.76 +91.55% -25.11% +116.66 9/28/2010 @ $26.35 2 Comments
TrackBrandes < 20 9/30/2007 Outperform NS $13.76 +91.55% -25.11% +116.66 9/28/2010 @ $26.35 2 Comments
TrackJimCramer 84.49 5/11/2007 Underperform 3W $18.86 +39.73% -24.25% -63.98 9/28/2010 @ $26.35 0 Comment
TrackJGreenblatt 68.63 1/1/2007 Outperform 1Y $20.03 -31.41% +3.69% -35.10 1/2/2008 @ $13.74 1 Comment
TrackBroadpointAmTech < 20 12/7/2006 Outperform NS $15.90 +65.72% -19.57% +85.28 9/28/2010 @ $26.35 0 Comment
TrackRBCCapMkts 87.95 9/26/2006 Outperform NS $11.25 +134.32% -13.75% +148.07 9/28/2010 @ $26.35 0 Comment
TrackBMOCapital < 20 8/22/2006 Outperform NS $15.55 -6.80% +11.72% -18.51 11/20/2007 @ $14.49 0 Comment

Featured Broker Partners